Mehdi Hamadani

104PUBLICATIONS
398CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyCardiovascular medicine and haematology not elsewhere classifiedBiological physicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (104)

|Sep 01, 2026
Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma.

|Aug 31, 2026
Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

|Aug 19, 2026
Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial.

|Jul 30, 2026
Regional practice differences significantly impact benefit from post-HCT gilteritinib for FLT3-ITD AML.

|Jul 08, 2026
Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee.

|May 22, 2026
Extranodal Male Genital Involvement With Diffuse Large B-Cell Lymphoma.

Pageof 18

Frequent Collaborators

16 joint publications

Mohamed Kharfan-Dabaja

14 joint publications

Narendranath Epperla

13 joint publications

Sairah Ahmed

12 joint publications

Nirav Shah